表紙画像

A Risk-Factor Model for Antineoplastic Drug-Induced Serious Adverse Events in Cancer Inpatients: A Retrospective Study Based on the Global Trigger Tool and Machine Learning

The objective of this study was to apply a machine learning method to evaluate the risk factors associated with serious adverse events (SAEs) and predict the occurrence of SAEs in cancer inpatients using antineoplastic drugs. A retrospective review of the medical records of 499 patients diagnosed wi...

保存先:

書誌詳細
主要な著者:	Ni Zhang (著者), Ling-Yun Pan (著者), Wan-Yi Chen (著者), Huan-Huan Ji (著者), Gui-Qin Peng (著者), Zong-Wei Tang (著者), Hui-Lai Wang (著者), Yun-Tao Jia (著者), Jun Gong (著者)
フォーマット:	図書
出版事項:	Frontiers Media S.A., 2022-06-01T00:00:00Z.
主題:	article
オンライン･アクセス:	Connect to this object online.
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients
著者:: Lunara Teles Silva, 等
出版事項: (2020)

Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients
著者:: Lunara Teles Silva, 等
出版事項: (2020)

Cardiovascular adverse events associated with oral antineoplastic therapy
著者:: Jacqueline Mota da Silva, 等

Predicting Adverse Drug Events in Chinese Pediatric Inpatients With the Associated Risk Factors: A Machine Learning Study
著者:: Ze Yu, 等
出版事項: (2021)

Establishing a trigger tool based on global trigger tools to identify adverse drug events in obstetric inpatients in China
著者:: Shan Wu, 等
出版事項: (2024)

Serious Neurological Adverse Events of Ceftriaxone
著者:: Clémence Lacroix, 等
出版事項: (2021)

The Brazilian Portuguese version of the Pediatric Trigger Toolkit is applicable to measure the occurrence of adverse drug events in Brazilian pediatric inpatients
著者:: Lunara Teles Silva, 等
出版事項: (2019)

The Brazilian Portuguese version of the Pediatric Trigger Toolkit is applicable to measure the occurrence of adverse drug events in Brazilian pediatric inpatients
著者:: Lunara Teles Silva, 等
出版事項: (2019)

Identification of small cell lung cancer patients who are at risk of developing common serious adverse event groups with machine learning
著者:: Linda Wanika, 等
出版事項: (2023)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
著者:: Colleen M. Kingsbury, 等
出版事項: (2024)

Surface Contamination by Antineoplastic Drugs in Two Oncology Inpatient Units
著者:: Palamini Marie, 等
出版事項: (2020)

Medication errors in a children's inpatient antineoplastic chemotherapy facility
著者:: Victoria E. Barrios-López, 等
出版事項: (2022)

Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoring
著者:: Ling Shu, 等
出版事項: (2024)

Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
著者:: William Queiroz Guimarães Wiegandt Ceglio, 等
出版事項: (2022)

Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events
著者:: Ben-Nian Huo, 等
出版事項: (2024)

HE USE OF TRIGGER TOOLSIN THE IDENTIFICATION OF ADVERSE DRUG EVENTS
著者:: Cleni Veroneze, 等
出版事項: (2017)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
著者:: Ming-Tao Wen, 等
出版事項: (2024)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
著者:: Matthew S. Duprey, 等
出版事項: (2019)

First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world
著者:: Jinmiao Lu, 等
出版事項: (2022)

Effect of an inpatient nursing risk early warning and control system in Shanghai: A retrospective study of adverse events
著者:: Qian Wu, 等
出版事項: (2015)

Incidence and management of the main serious adverse events reported after COVID‐19 vaccination
著者:: Teresa Padilla‐Flores, 等
出版事項: (2024)

Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database
著者:: Dongxuan Li, 等
出版事項: (2024)

Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self‐controlled case series analysis
著者:: Sherrie L. Aspinall, 等
出版事項: (2020)

Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis.
著者:: Sauman Singh-Phulgenda, 等
出版事項: (2021)

Hypersensitivity Reactions in Serious Adverse Events Reported for Paracetamol in the EudraVigilance Database, 2007-2018
著者:: Iwona Popiołek, 等
出版事項: (2019)

Serious Adverse Events Reporting in Phase III Randomized Clinical Trials of Colorectal Cancer Treatments: A Systematic Analysis
著者:: Yanhong Yao, 等
出版事項: (2021)

Introduction of antineoplastic drug NSC631570 in an inpatient and outpatient setting: Comparative evaluation of biological effects
著者:: Mariia Rudyk, 等
出版事項: (2016)

Machine learning approach to identify adverse events in scientific biomedical literature
著者:: Sonja Wewering, 等
出版事項: (2022)

Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data
著者:: Yiming Li, 等
出版事項: (2024)

Trackers for Adverse Events in Child Mental Health: descriptive analysis using the global trigger tool
著者:: Sandna Larissa Freitas dos Santos, 等
出版事項: (2023)

Active monitoring of antifungal adverse events in hospitalized patients based on Global Trigger Tool method
著者:: Xiao Meng, 等
出版事項: (2024)

Naloxone as a trigger to identify opioid-related adverse events in pediatric intensive care units
著者:: Haline Ogata, 等
出版事項: (2019)

Fact-Finding Survey and Exploration of Preventive Drugs for Antineoplastic Drug-Induced Oral Mucositis Using the Japanese Adverse Drug Event Report Database
著者:: Hajime Matsuo, 等
出版事項: (2024)

Joint association of sleep duration and physical activity with cognitive performance among Chinese adults: an analysis of nationally representative survey data
著者:: Huan Tao, 等
出版事項: (2023)

A comparative analysis on serious adverse events reported for COVID-19 vaccines in adolescents and young adults
著者:: Beniamino Cappelletti-Montano, 等
出版事項: (2023)

Establishment of a pediatric trigger tool based on Global Trigger Tool to identify adverse drug events of children: experience in a Chinese hospital
著者:: Yi Liu, 等
出版事項: (2020)

Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system
著者:: Pernille Kähler Byskov, 等
出版事項: (2024)

A systematic review of gastritis as an immune-related adverse event in clinical interventions
著者:: Fei Su, 等
出版事項: (2024)

Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
著者:: Jing Huang, 等
出版事項: (2020)

Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023
著者:: Yihan Yang, 等
出版事項: (2024)